Effects of glucocorticoids on mood, memory, and the hippocampus: Treatment and preventive therapy

Annals of the New York Academy of Sciences

Volumn 1179, Issue , 2009, Pages 41-55

  Brown, E Sherwood ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Corticosteroid; Depression; Glutamate; Mania; Memory; Psychosis

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; DEXAMETHASONE; ETIRACETAM; FLUOXETINE; GABAPENTIN; GLUCOCORTICOID; HYDROCORTISONE; LAMOTRIGINE; LITHIUM; MEMANTINE; NEUROLEPTIC AGENT; OLANZAPINE; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; PLACEBO; PREDNISONE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

ANXIETY; ANXIETY DISORDER; ASTHMA; ATTENTION; BRAIN ATROPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DELIRIUM; DEMENTIA; DEPERSONALIZATION; DEPRESSION; DRUG ABUSE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MEGADOSE; DRUG OVERDOSE; ENERGY; GENDER; HIPPOCAMPUS; HUMAN; HYPOMANIA; INSOMNIA; IRRITABILITY; LONG TERM CARE; LOW DRUG DOSE; MANIA; MEMORY; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL DISEASE; MENTAL INSTABILITY; MOOD; MOOD CHANGE; NEUROIMAGING; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PSYCHOSIS; SIDE EFFECT; SINGLE DRUG DOSE; SUICIDAL IDEATION; TEMPORAL LOBE; TREATMENT DURATION; VERBAL MEMORY; WITHDRAWAL SYNDROME; WORKING MEMORY;

ADRENAL CORTEX HORMONES; ADULT; AFFECT; ANIMALS; CASE-CONTROL STUDIES; CHILD; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HIPPOCAMPUS; HUMANS; LITHIUM COMPOUNDS; MEMORY; MODELS, BIOLOGICAL; MOOD DISORDERS; PHENYTOIN; TREATMENT OUTCOME;

EID: 70449413778     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04981.x     Document Type: Conference Paper

References (106)

1. Fardet, L., A. Kassar, J. Cabane, et al. 2007. Corticosteroid-induced adverse events in adults: Frequency, screening and prevention. Drug Saf. 30: 861-881. (Pubitemid 47481442)
2. Borman, M.C. & H.C. Schmallenberg. 1951. Suicide following cortisone treatment. J. Am.Med. Assoc. 146: 337-338.
3. Rees, L. 1953. Psychological concomitants of cortisone and ACTH therapy. J. Ment. Sci. 99: 497-504.
4. Rome, H.P. & F.J. Braceland. 1952. The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am. J. Psychiatry 108: 641-651.
5. Brown, E.S. & T. Suppes. 1998. Mood symptoms during corticosteroid therapy: A review. Harv. Rev. Psychiatry 5: 239-246.
6. Kershner, P. & R. Wang-Cheng. 1989. Psychiatric side effects of steroid therapy. Psychosomatics 30: 135-139.
7. Lewis, A. & J.J. Fleminger. 1954. The psychiatric risk from corticotrophin and cortisone. Lancet 266: 383-386.
8. Ling, M.H., P.J. Perry & M.T. Tsuang. 1981. Side effects of corticosteroid therapy. Psychiatric aspects. Arch. Gen. Psychiatry 38: 471-477.
9. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. American Psychiatric Press. Washington, DC.
10. van Staa, T.P., H.G. Leufkens, L. Abenhaim, et al. 2000. Use of oral corticosteroids in the United Kingdom. QJM 93: 105-111. (Pubitemid 30098773)
11. Ettinger, B., A. Pressman & A. Shah. 2001. Whobears responsibility for glucocorticoid-exposedpatients in a large health maintenance organization? J. Manag. Care Pharm. 7: 228-232.
12. Brown, E.S., A.J. Rush & B.S. McEwen. 1999. Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders. Neuropsychopharmacology 21: 474-484.
13. Lupien, S.J. & B.S. McEwen. 1997. The acute effects of corticosteroids on cognition: Integration of animal and human model studies. Brain Res. Brain Res. Rev. 24: 1-27.
14. Lewis, D.A. & R.E. Smith. 1983. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J. Affect. Disord. 5: 319-332.
15. Naber, D., P. Sand & B. Heigl. 1996. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 21: 25-31.
16. Brown, E.S., T. Suppes, D.A. Khan, et al. 2002. Mood changes during prednisone bursts in outpatients with asthma. J. Clin. Psychopharmacol. 22: 55-61.
17. Wolkowitz, O.M., D. Rubinow, A.R. Doran, et al. 1990. Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch. Gen. Psychiatry 47: 963-968.
18. Bender, B.G., J.A. Lerner & E. Kollasch. 1988. Mood and memory changes in asthmatic children receiving corticosteroids. J. Am. Acad. Child Adolesc. Psychiatry 27: 720-725.
19. Varney, N.R., B. Alexander & J.H. MacIndoe. 1984. Reversible steroid dementia in patients without steroid psychosis. Am. J. Psychiatry 141: 369-372.
20. Wolkowitz, O.M., S.J. Lupien, E. Bigler, et al. 2004. The "steroid dementia syndrome": An unrecognized complication of glucocorticoid treatment. Ann. N. Y. Acad. Sci. 1032: 191-194.
21. Brown,E.S., L. Beard, A.B. Frol, et al. 2006. Effect of two prednisone exposures on mood and declarative memory. Neurobiol. Learn. Mem. 86: 28-34.
22. Newcomer, J.W., G. Selke, A.K. Melson, et al. 1999. Decreasedmemory performance in healthy humans induced by stress-level cortisol treatment. Arch. Gen. Psychiatry 56: 527-533.
23. Newcomer, J.W., S. Craft, T. Hershey, et al. 1994. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J. Neurosci. 14: 2047-2053.
24. Keenan, P.A., M.W. Jacobson, R.M. Soleymani, et al. 1996. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 47: 1396-1402.
25. Eichenbaum, H., T. Otto & N.J. Cohen. 1992. The hippocampus-what does it do? Behav. Neural Biol. 57: 2-36.
26. Squire, L.R. 1992. Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99: 195-231.
27. Wolkowitz, O.M., V.I. Reus, H. Weingartner, et al. 1990. Cognitive effects of corticosteroids. Am. J. Psychiatry 147: 1297-1303.
28. Zobel, A.W., S. Schulze-Rauschenbach, O.C. von Widdern, et al. 2004. Improvement of working but not declarativememory is correlated withHPA normalization during antidepressant treatment. J. Psychiatr. Res. 38: 377-383.
29. Lupien, S.J.,C.J. Gillin&R.L.Hauger. 1999.Workingmemory ismore sensitive than declarativememory to the acute effects of corticosteroids: A doseresponse study in humans. Behav. Neurosci. 113: 420-430.
30. Young, A.H., B.J. Sahakian, T.W. Robbins, et al. 1999. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl.) 145: 260-266.
31. Ganguli, R., A. Singh, J. Brar, et al. 2002. Hydrocortisone induced regional cerebral activity changes in schizophrenia: A PET scan study. Schizophr. Res. 56: 241-247.
32. de Leon, M.J., T. McRae, H. Rusinek, et al. 1997. Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J. Clin. Endocrinol. Metab. 82: 3251-3259.
33. de Quervain, D.J., K. Henke, A. Aerni, et al. 2003. Glucocorticoid- induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur. J. Neurosci. 17: 1296-1302.
34. Chiron, C., C. Dumas, I. Jambaque, et al. 1997. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 26: 389-395.
35. de Tiege, X., S. Goldman, S. Laureys, et al. 2004. Regional cerebral glucose metabolism in epilepsies with continuous spikes and waves during sleep. Neurology 63: 853-857.
36. Lucassen, P.J.,M.B.Muller, F. Holsboer, et al. 2001. Hippocampal apoptosis in major depression is aminor event and absent fromsubareas at risk for glucocorticoid overexposure.Am. J. Pathol. 158: 453-468.
37. Muller, M.B., P.J. Lucassen, A. Yassouridis, et al. 2001. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur. J. Neurosci. 14: 1603-1612.
38. Bolanos, S.H., D.A. Khan, M. Hanczyc, et al. 2004. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann. Allergy Asthma Immunol. 92: 500-505.
39. 39. Gift, A.G., R.M. Wood & C.A. Cahill. 1989. Depression, somatization and steroid use in chronic obstructive pulmonary disease. Int. J. Nurs. Stud. 26: 281-286.
40. Zhao, Y., R. Ma, J. Shen, et al. 2008. A mouse model of depression induced by repeated corticosterone injections. Eur. J. Pharmacol. 581: 113-120.
41. Magarinos, A.M., J.M.G. Verdugo & B.S. McEwen. 1997. Chronic stress alters synaptic terminal structure in hippocampus. Proc.Natl. Acad. Sci. 94: 14002-14008.
42. Vyas, A., R. Mitra, B.S. Shankaranarayana Rao, et al. 2002. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 22: 6810-6818.
43. Uno, H., R. Tarara, J.G. Else, et al. 1989. Hippocampal damage associated with prolonged and fatal stress in primates. J. Neurosci. 9: 1705-1711.
44. Uno, H., S. Eisele, A. Sakai, et al. 1994. Neurotoxicity of glucocorticoids in the primate brain. Horm. Behav. 28: 336-348.
45. Sapolsky, R.M., H. Uno, C.S. Rebert, et al. 1990. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J. Neurosci. 10: 2897-2902.
46. Leverenz, J.B., C.W. Wilkinson, M. Wamble, et al. 1999. Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. J. Neurosci. 19: 2356-2361.
47. Bermond, B., S. Surachno, A. Lok, et al. 2005. Memory functions in prednisone-treated kidney transplant patients. Clin. Transplant. 19: 512-517.
48. Bentson, J., M. Reza, J. Winter, et al. 1978. Steroids and apparent cerebral atrophy on computed tomography scans. J. Comput. Assist. Tomogr. 2: 16-23.
49. Okuno, T., M. Ito, Y. Konishi, et al. 1980. Cerebral atrophy following ACTH therapy. J. Comput. Assist. Tomogr. 4: 20-23.
50. Wilner, A.P., B. de Varennes, P.A. Gregoire, et al. 2002. Glucocorticoids and hippocampal atrophy after heart transplantation. Ann. Thorac. Surg. 73: 1965-1967.
51. Brown, E.S., J. Woolston, A. Frol, et al. 2004. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol. Psychiatry 55: 538-545.
52. Brown, E.S., D.J. Woolston & A.B. Frol. 2008. Amygdala volume in patients receiving chronic corticosteroid therapy. Biol. Psychiatry 63: 705-709.
53. Brown, E.S., E.Vera, A.B. Frol, et al. 2007. Effects of chronic prednisone therapy on mood and memory. J. Affect. Disord. 99: 279-283.
54. Hajek, T., M. Kopecek, M. Preiss, et al. 2006. Prospective study of hippocampal volume and function in human subjects treated with corticosteroids. Eur. Psychiatry 21: 123-128.
55. Coluccia, D., O.T. Wolf, S. Kollias, et al. 2008. Glucocorticoid therapy-induced memory deficits: Acute versus chronic effects. J. Neurosci. 28: 3474-3478.
56. Stoudemire, A., T. Anfinson & J. Edwards. 1996. Corticosteroid- induced delirium and dependency. Gen. Hosp. Psychiatry 18: 196-202.
57. Ortega, L.D. & R.G. Grande. 1979. Cushing's syndrome due to abuse of dexamethasone nasal spray. Lancet 2: 96.
58. Brown, E.S. 1997. Chemical dependence involving glucocorticoids. Ann. Clin. Psychiatry 9: 185-187.
59. Dixon, R.B. & N.P. Christy. 1980. On the various forms of corticosteroid withdrawal syndrome. Am. J. Med. 68: 224-230.
60. Fricchione, G., M. Ayyala & V.F. Holmes. 1989. Steroid withdrawal psychiatric symptoms. Ann. Clin. Psychiatry 1: 99-108.
61. Venkatarangam, S.H., S.P.Kutcher &R.M.Notkin. 1988. Secondary mania with steroid withdrawal. Can. J. Psychiatry 33: 631-632.
62. Campbell, K.M. & D.S. Schubert. 1991. Delirium after cessation of glucocorticoid therapy. Gen. Hosp. Psychiatry 13: 270-272.
63. Goldberg, R.L. & T.N. Wise. 1986. Corticosteroid abuse revisited. Int. J. Psychiatry Med. 16: 145-149.
64. Kreus, K.E., A.A. Viljanen, E. Kujala, et al. 1975. Treatment of steroid-dependent asthma patients with beclomethasone dipropionate aerosol. Scand. J. Respir. Dis. 56: 47-57.
65. The Boston Collaborative Surveillance Program. 1972. Acute adverse reactions to prednisone in relation to dosage. Clin. Pharmacol. Ther. 13: 694-698.
66. Olsen, E.A., S.C. Carson & E.A. Turney. 1992. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch. Dermatol. 128: 1467-1473.
67. Boye Nielsen, J., A. Drivsholm, F. Fischer, et al. 1963. Long-term treatment with corticosteroids in rheumatoid arthritis (over a period of 9 to 12 years). Acta Med. Scand. 173: 177-183.
68. Hayreh, S.S. & P.G. Watson. 1970. Prednisolone- 21-stearoylglycolate in scleritis. Br. J. Ophthalmol. 54: 394-398.
69. Bremner, J.D.,M. Vythilingam, E. Vermetten, et al. 2004. Effects of glucocorticoids on declarativememory function in major depression. Biol. Psychiatry 55: 811-815.
70. Bremner, J.D.,M. Vythilingam, E. Vermetten, et al. 2004. Effects of dexamethasone on declarative memory function in posttraumatic stress disorder. Psychiatry Res. 129: 1-10. (Pubitemid 39574432)
71. 71. Kuhlmann, S. & O.T. Wolf. 2005. Cortisol and memory retrieval in women: Influence of menstrual cycle and oral contraceptives. Psychopharmacology (Berl.) 183: 65-71. (Pubitemid 41484183)
72. Sapolsky, R.M. 2001. Cellular defenses against excitotoxic insults. J. Neurochem. 76: 1601-1611.
73. McEwen, B.S. 2000. Allostasis, allostatic load, and the aging nervous system: Role of excitatory amino acids and excitotoxicity. Neurochem. Res. 25: 1219-1231.
74. Ioannou, N., C. Liapi, C.E. Sekeris, et al. 2003. Effects of dexamethasone on K(+)-evoked glutamate release from rat hippocampal slices. Neurochem. Res. 28: 875-881.
75. Magarinos, A.M., B.S. McEwen, G. Flugge, et al. 1996. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J. Neurosci. 16: 3534-3540.
76. Magarinos, A.M. & B.S. McEwen. 1995. Stressinduced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69: 89-98.
77. Watanabe, Y., E. Gould, D.C. Daniels, et al. 1992. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur. J. Pharmacol. 222: 157-162.
78. Falk,W.E., M.W. Mahnke & D.C. Poskanzer. 1979. Lithium prophylaxis of corticotropin-induced psychosis. JAMA 241: 1011-1012.
79. Brown, E.S., G. Stuard, J.D. Liggin, et al. 2005. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. Biol. Psychiatry 57: 543-548.
80. Hanon, E. & H. Klitgaard. 2001. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 10: 287-293.
81. Marini, H., C. Costa, M. Passaniti, et al. 2004. Levetiracetam protects against kainic acid-induced toxicity. Life Sci. 74: 1253-1264.
82. Ueda, Y., T. Doi, K. Nagatomo, et al. 2007. Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection. Brain Res. 1151: 55-61.
83. Brown, E.S., A.B. Frol, D.A. Khan, et al. 2007. Impact of levetiracetam on mood and cognition during prednisone therapy. Eur. Psychiatry 22: 448-452.
84. Brown, E.S., J. Wolfshohl, M.U. Shad, et al. 2008. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine. Neuropsychopharmacology 33: 2376-2383.
85. Brown, E.S., M. Vazquez & A. Nakamura. 2008. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy. Biol. Psychiatry 64: 727-729.
86. Brown, E.S., A. Frol, L. Bobadilla, et al. 2003. Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids. Psychosomatics 44: 204-208.
87. Brown, E.S., D.A. Khan & T. Suppes. 1999. Treatment of corticosteroid-induced mood changes with olanzapine. Am. J. Psychiatry 156: 968.
88. Goldman, L.S.&J. Goveas. 2002. Olanzapine treatment of corticosteroid-induced mood disorders. Psychosomatics 43: 495-497.
89. Brown, E.S., W. Chamberlain, N. Dhanani, et al. 2004. An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J. Affect. Disord. 83: 277-281.
90. DeSilva, C.C., M.C. Nurse & K. Vokey. 2002. Steroid-induced psychosis treated with risperidone. Can. J. Psychiatry 47: 388-389.
91. Siddiqui, Z., S. Ramaswamy & F. Petty. 2005. Quetiapine therapy for corticosteroid-induced mania. Can. J. Psychiatry 50: 77-78.
92. Ahmad, M. & F.M. Rasul. 1999. Steroid-induced psychosis treated with haloperidol in a patient with active chronic obstructive pulmonary disease. Am. J. Emerg. Med. 17: 735.
93. Blazer, D.G., W.M. Petrie & W.P. Wilson. 1976. Affective psychoses following renal transplant. Dis. Nerv. Syst. 37: 663-667.
94. Hall, R.C.,M.K. Popkin, S.K. Stickney, et al. 1979. Presentation of the steroid psychoses. J. Nerv. Ment. Dis. 167: 229-236.
95. Kahn, D., E. Stevenson & C.J. Douglas. 1988. Effect of sodium valproate in three patients with organic brain syndromes. Am. J. Psychiatry 145: 1010-1011.
96. Wada, K., N. Yamada, T. Sato, et al. 2001. Corticosteroid-induced psychotic and mood disorders: Diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 42: 461-466.
97. Ginsberg, D.L. & N. Sussman. 2001. Gabapentin as prophylaxis against steroid-induced mania. Can. J. Psychiatry 46: 455-456.
98. Viswanathan, R. & L. Glickman. 1989. Clonazepam in the treatment of steroid-induced mania in a patient after renal transplantation. N. Engl. J. Med. 320: 319-320.
99. Kemp, K., J.R. Lion & G. Magram. 1977. Lithium in the treatment of a manic patient with multiple sclerosis: A case report. Dis. Nerv. Syst. 38: 210-211.
100. Lynn,D.J. 1995. Lithium in steroid-induced depression. Br. J. Psychiatry 166: 264
101. 101. Bartoszek, M., A.M. Brenner & S.J. Szefler. 1987. Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy. Clin. Pharmacol. Ther. 42: 424-432.
102. Hall, R.C., M.K. Popkin & B. Kirkpatrick. 1978. Tricyclic exacerbation of steroid psychosis. J. Nerv. Ment. Dis. 166: 738-742.
103. Beshay,H.&A.J. Pumariega. 1998. Sertraline treatment of mood disorder associated with prednisone: A case report. J. Child Adolesc. Psychopharmacol. 8: 187-193.
104. Wyszynski, A.A. & B. Wyszynski. 1993. Treatment of depression with fluoxetine in corticosteroiddependent central nervous system Sjogren's syndrome. Psychosomatics 34: 173-177.
105. Ismail, M. & G. Lyster. 2002. Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome. Ir. Med. J. 95: 18-19.
106. Brown, C.K., G. Meeker & E.S. Brown. 2005. Examination of a possible interaction between prednisone and newer antidepressants. Prim. Care Community Psychiatry. 10: 143-147S